Repligen Corp. (RGEN)

162.33 -5.60 (-3.33%) USD  |  NASDAQ  |  Jan 23, 16:00
162.28 -0.05 (-0.03%) After-Hours: 20:00
More

Repligen Operating Income (Quarterly YoY Growth)

Operating Income (Quarterly YoY Growth) Chart

View Operating Income (Quarterly YoY Growth) for RGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Quarterly YoY Growth) Range, Past 5 Years

View Operating Income (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Quarterly YoY Growth) Benchmarks

View Operating Income (Quarterly YoY Growth) Benchmarks
Start Trial
Enovis Corp. Upgrade
Perspective Therapeutics, Inc. Upgrade
InfuSystem Holdings, Inc. Upgrade
Xtant Medical Holdings, Inc. Upgrade
VolitionRX Ltd. Upgrade